Join to View Full Profile
257 Lafayette AveSuite 330Suffern, NY 10901
Phone+1 845-368-8808
Fax+1 845-368-5608
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 2 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jordan Dubow, MD is a board certified neurologist in Suffern, New York. He is currently licensed to practice medicine in New York, Michigan, and Illinois.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Vascular Neurology, 2010 - 2011
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 2003 - 2006
Northwestern University The Feinberg School of MedicineClass of 2003
Certifications & Licensure
IL State Medical License 2004 - 2026- IL State Medical License 2007 - 2026
MI State Medical License 2011 - 2012
NY State Medical License 2009 - 2011
American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 10 citationsPharmacokinetics of FT218, a Once-Nightly Sodium Oxybate Formulation in Healthy Adults.David Seiden, Charles Tyler, Jordan Dubow
Clinical Therapeutics. 2021-02-23 - 116 citationsEfficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophyRobert C. Griggs, J. Phillip Miller, Cheryl R. Greenberg, Darcy Fehlings, Alan Pestronk
Neurology. 2016-11-15 - 59 citationsSublingual apomorphine (APL-130277) for the acute conversion of OFF to ON in Parkinson's disease.Robert A. Hauser, C. Warren Olanow, Bruce Dzyngel, Thierry Bilbault, Holly A. Shill
Movement Disorders. 2016-09-01
Press Mentions
Revalesio Receives FDA Fast Track Designation for RNS60 for the Treatment of Acute Ischemic StrokeJuly 31st, 2025- Revalesio Announces New Analyses from Phase 2 RESCUE Study of RNS60 in Patients with Acute Ischemic Stroke in Oral Presentation at the International Stroke Conference 2025February 5th, 2025
- Paragon Biosciences' CEO Jeff Aronin Names Jordan Dubow New Chief Medical OfficerApril 15th, 2021
